-
How to deal with a temporary suspension and restarting your trial
Whilst the issues around early termination of randomised controlled trials (RCTs) are well documented in the literature, trials can also be temporarily suspended with the real prospect that they may subsequently restart. There is little guidance in the literature as to how to manage such a temporary suspension. Researchers working...
-
Trial management during the COVID-19 pandemic and beyond
Trial managers have faced unprecedented challenges during the COVID-19 pandemic. A number of Trial Managers from the Centre for Healthcare Randomised Trials (CHaRT), in collaboration with other Trial Managers from the UK Trial Managers Network (UKTMN), contributed towards the recently published article on the way trial management processes have been...
-
Designing Real World Trials short course continues for the third year
Experts from our Clinical Trials Unit (CHaRT) and HSRU deliver a 12 week short course on Designing Real World Trials. This course takes you through the process of designing a randomised controlled trial (RCT). The course will focus on trials in the evaluation of real-world healthcare and public health settings. The...
-
Staff News - August 2020
Huge congratulations to Giles O’Donovan (Dr Giles from now on!) who successfully defended his PhD thesis last month. We look forward to having a proper celebration with you once we’re back in the office. Best of luck to Jess Wood who is moving up to the beautiful Isle of Lewis this...
-
Staff News - July 2020
Farewell to Sarah Cameron who leaves us at the end of this month to take up a post with TauRX. Sarah will still be in and around the University campus, so we look forward to bumping into her occasionally - best of luck in your new role Sarah!
-
Multi-million investment in six new research projects to investigate Covid-19 and ethnicity
The University of Aberdeen is leading one of six new projects to improve our understanding of the links between Covid-19 and ethnicity, funded by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR).
-
HSRU's Clare Robertson wins a Principal's Prize for Research and Engagement
The Principal's Prizes for Research and Engagement are intended to recognise outstanding contributions in research, impact and engagement. We are delighted that HSRU's Clare Robertson has won this years Outstanding Achievement in Biomedical Sciences. This is a special prize awarded to recognise outstanding achievement in biomedical sciences engagement. This is the 6th...
-
BAME individuals must not be under-represented in Covid-19 research
Researchers must ensure people of Black, Asian and Minority Ethnic (BAME) groups are proportionately represented in Covid-19 studies, according to scientists from UK and USA.
-
Total versus partial knee replacement in patients with medial compartment knee osteoarthritis
Late-stage medial compartment knee osteoarthritis (OA) can be treated using total knee replacement (TKR) or partial (unicompartmental) knee replacement (PKR). It is not known which replacement offers most benefit for the patient or for the health-care system. TOPKAT was designed as a multicentre parallel-group superiority randomised controlled trial (RCT) to evaluate...
-
Trial Forge is creating practical resources for trial teams in response to COVID-19
COVID-19 is affecting the way we all do randomised trials and the Trial Forge team has been providing a range of materials that are relevant to both COVID-19 trials and non-COVID trials affected by COVID-19 (https://www.trialforge.org/covid-19-resources/). Currently these materials fall into three main categories:• Evidence pack: up-to-date summaries of evidence for...